CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in preventing leukemia return after transplant
Disease control Recruiting nowThis early-phase study tests the safety and best dose of revumenib, a drug that blocks a protein fueling leukemia growth, in 27 adults and children with specific genetic types of acute leukemia. Participants take revumenib after a stem cell transplant to help keep the cancer from…
Matched conditions: CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Leukemia Drug's clotting risks under microscope in new study
Knowledge-focused Recruiting nowThis study looks at how the chemotherapy drug calaspargase pegol changes blood clotting in children with acute lymphoblastic leukemia (ALL). Researchers will take blood samples before and after treatment to track clotting changes and any related side effects. The goal is to bette…
Matched conditions: CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 01:20 UTC